HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Detar, D T. Articles by Chessman, A. W Search for Related Content PubMed PubMed Citation Articles by Detar, D T. Articles by Chessman, A. W Topic Collections Related Article

Physiotherapy plus a craniocervical training programme was better than physiotherapy alone in tension type headache

Clinical impact ratings GP/FP/Primary care Neurology Physical medicine & rehabilitation

Key Words: biofeedback (psychology) • exercise therapy • musculoskeletal manipulations • tension type headache

The first 150 words of the full text of this article appear below.

METHODS
Design: randomised controlled trial.

Allocation: {concealed^*}.

Blinding: blinded ({data collectors and data analysts}).^*

Follow up period: 6 months.

Setting: 7 healthcare centres in the Netherlands.

Patients: 81 patients (mean age 46 y, 81% female) with a diagnosis of TTH based on the International Headache Society classification (including the episodic and chronic versions). Exclusion criteria were the other headache types, cervical function problems, or previous physiotherapy treatment for TTH within 6 months.

Intervention: CTP, 10 min/session, twice a day at home, plus physiotherapy, {1–2 sessions/week, maximum 9 sessions} (n = 39); or physiotherapy alone (n = 42) for 6 weeks. Physiotherapy included conventional Western massage techniques, oscillation techniques, and instruction on postural correction. The CTP was a craniocervical flexion exercise performed using a 150 cm latex band (Thera-Band, Resistive Exercise Systems; Hygenic Corporation, Akron, OH, USA; blue colour coded level of progressive resistance) that was used as a . . . [Full text of this article]

D Todd Detar, DO, Alexander W Chessman, MD

Medical University of South Carolina,
Charleston, South Carolina, USA

Related Article

Other articles noted
Evid. Based Med. 2007 12: 31-32. (in ) [Extract] [Full Text] [PDF]